Results 71 to 80 of about 169 (158)

Association Between Participant Satisfaction and Self‐Reported Clinical Practice Behaviors in a Nationwide Guideline Education Program

Neuropsychopharmacology Reports, Volume 46, Issue 3, September 2026.
Higher satisfaction with nationwide guideline education programs was associated with greater self‐reported guideline‐concordant clinical behaviors among psychiatrists in Japan. These findings suggest that positive educational experiences may support implementation of evidence‐based psychiatric practice. ABSTRACT Background Educational interventions are
Kazuhiko Yamamuro, Kenta Ide, Yusuke Arai, Hiroyuki Muraoka, Toru Horinouchi, Yasushi Kawamata, Keisuke Mori, Shinichiro Ochi, Takashi Tsuboi, Hirotaka Yamagata, Hitoshi Iida, Yuka Yasuda, Junya Matsumoto, Naoki Hashimoto, Kazutaka Ohi, Toshiaki Onitsuka, Hisashi Yamada, Shusuke Numata, Hikaru Hori, Ken Inada, Koichiro Watanabe, Norio Yasui‐Furukori, Ryota Hashimoto   +22 more
wiley   +1 more source

Trial‐History Effects During WCST in Treatment‐Resistant Schizophrenia

Neuropsychopharmacology Reports, Volume 46, Issue 3, September 2026.
In the WCST, participants must use feedback from each trial to update their subsequent choices. Trial‐level analysis revealed that previous‐trial correctness modulated reaction time, with a weaker post‐error slowing‐like effect in TRS compared with non‐TRS participants.
Ryo Sawagashira, Atsuhito Toyomaki, Hayato Watanabe, Naoki Hashimoto, Takahiro A. Kato   +4 more
wiley   +1 more source

Digital and Biomarker‐Based Monitoring for Schizophrenia‐Treatment Adherence

Neuropsychopharmacology Reports, Volume 46, Issue 3, September 2026.
Monitoring technologies integrated with artificial intelligence can enable personalized care, improved adherence, and reduced relapses among psychotic patients. ABSTRACT Background Nonadherence to antipsychotics affects nearly half of patients with schizophrenia, leading to rehospitalization, suicidality, and reduced quality of life.
Samuel Inshutiyimana, Kush Rajeshbhai Rana, Michael Matiop Aleu, Naomi Bwalya, Bonaventure Nsengimana, Onesmas Kipkurui   +5 more
wiley   +1 more source

Nationwide expansion of the EGUIDE project in Japan: A nine‐year overview

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Abstract Aim This study aimed to describe the nationwide reach, longitudinal growth, and geographic dissemination of the Effectiveness of Guideline for Dissemination and Education in Psychiatric Treatment (EGUIDE) project in Japan from 2016 to 2024. Methods The EGUIDE project is a nationwide, multicenter implementation initiative designed to promote ...
Hiroyuki Muraoka, Keisuke Mori, Takashi Tsuboi, Hitoshi Iida, Kentaro Fukumoto, Kazutaka Ohi, Kayo Ichihashi, Jun‐ichi Iga, Yuka Yasuda, Toshinori Nakamura, Eiichi Katsumoto, Tatsuya Nagasawa, Shusuke Numata, Shinichiro Ochi, Hirotaka Yamagata, Tomoyasu Wakuda, Masahiro Takeshima, Fumitoshi Kodaka, Yasushi Kawamata, Toru Horinouchi, Kazuhiko Yamamuro, Yusuke Arai, Satsuki Ito, Junya Matsumoto, Hisashi Yamada, Hikaru Hori, Ken Inada, Koichiro Watanabe, Norio Yasui‐Furukori, Ryota Hashimoto   +29 more
wiley   +1 more source

Pre‐corticosteroid delusional psychosis and olanzapine‐responsive behavioral dyscontrol in autoimmune glial fibrillary acidic protein astrocytopathy: A case report

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Abstract Background Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is an immunotherapy‐responsive inflammatory central nervous system disorder. Psychiatric manifestations include delirium, cognitive or behavioral change, apathy, depressive symptoms, and anxiety; however, frank delusional psychosis before corticosteroid exposure is ...
Tomomi Sugisaki, Yoshiteru Sato, Hiroaki Fujita, Yasushi Kawamata, Norio Sugawara, Keisuke Suzuki, Norio Yasui‐Furukori   +6 more
wiley   +1 more source

Psychiatric effects of cannabidiol, cannabinol, and tetrahydrocannabinol: A narrative review of clinical evidence and risk profiles

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Abstract Cannabinoid products are increasingly used worldwide despite limited psychiatric evidence. This narrative review synthesizes preclinical and clinical evidence on cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabinol (THC) to clarify their distinct psychiatric profiles and discuss how current evidence may inform ongoing clinical and ...
Yasuhiro Kishi, Ichiro Takumi, Kakusho Chigusa Nakajima‐Ohyama   +2 more
wiley   +1 more source

Development and Clinical Utility of Machine Learning Models for Prediction of Same‐Day Discharge in Outpatient Hip and Knee Replacement: A Prognostic Study

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 8, September 2026.
ABSTRACT Background Hip and knee replacement are common procedures with an increasing focus on same‐day surgery. However, capacity constraints limit the number of eligible patients actually being scheduled for same‐day discharge, calling for further selection of those with the highest likelihood of same‐day discharge.
Christoffer C. Jørgensen, Jakob B. Frederiksen, Henrik Kehlet, Martin Lindberg‐Larsen, Kirill Gromov, Claus Varnum, Thomas Jakobsen, Manuel Josef Bieder, Mikkel Rathsach Andersen, Søren Overgaard, Torben B. Hansen, Troels Petersen   +11 more
wiley   +1 more source

Psychiatric History and Postpartum Depression: The Mediating Role of Obstetric Complications

Acta Psychiatrica Scandinavica, Volume 154, Issue 3, Page 223-233, September 2026.
ABSTRACT Introduction Psychiatric history is the strongest risk factor for postpartum depression (PPD). Obstetric complications, more prevalent among women with a psychiatric history, are also independent risk factors. However, the mechanisms linking these factors to PPD remain unclear.
Mette‐Marie Zacher Kjeldsen, Katrine Holde, Line Bager, Veerle Bergink, Emely Ek Blæhr, Janne Tidselbak Larsen, Kathrine Bang Madsen, Merete Lund Mægbæk, Liselotte Vogdrup Petersen, Trine Munk‐Olsen   +9 more
wiley   +1 more source

Sexual Safety Signals of Common Antidiabetic Drugs: Insights From FAERS Disproportionality Analysis

Andrology, Volume 14, Issue 6, Page 1627-1635, September 2026.
ABSTRACT Background Erectile dysfunction is a prevalent and distressing complication of diabetes mellitus that markedly affects quality of life in male patients. Although the role of diabetes in erectile dysfunction is well‐established, potential drug‐induced sexual dysfunction associated with commonly prescribed antidiabetic medications remains ...
Shan Lin, Xuefeng Ding, Xin Dang, Qingyuan Zhan   +3 more
wiley   +1 more source

Deprescription of Psychotropics in Children and Adolescents: Systematic Review of Guidelines and Development of a Deprescribing Algorithm

Basic &Clinical Pharmacology &Toxicology, Volume 139, Issue 3, September 2026.
ABSTRACT Background Psychotropics are increasingly prescribed in paediatrics despite limited evidence regarding their benefits and effectiveness. Although deprescribing approaches are established in adults, structured paediatric strategies remain poorly defined.
Paul‐Benoît Fargier, Mark Horowitz, Rodolphe Charles, Valérie Rousselon, Erik Fakra, Marie‐Noëlle Beyens, Marie‐Laure Laroche   +6 more
wiley   +1 more source